<DOC>
	<DOCNO>NCT02001935</DOCNO>
	<brief_summary>The aim study determine whether common CYP1A2 CYP2E1 gene polymorphism effect metabolism theophylline chronic obstructive pulmonary disease patient .</brief_summary>
	<brief_title>Association Between CytochromeP4501A2 CytochromeP4502E1 Gene Polymorphisms Metabolism Theophylline</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Aged 1875 year , COPD patient , male female ; regularly visit hospital ; take sustainedrelease preparation theophylline continuously least 2 week patient renal hepatic dysfunction ; patient congestive heart failure ; patient hypothyroidism hyperthyroidism ; patient currently take drug likely affect theophylline metabolism take drug precede week ; patient extreme obesity patient severe Chronic Obstructive Pulmonary Disease ( COPD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>COPD</keyword>
	<keyword>theophylline</keyword>
	<keyword>CYP1A2</keyword>
	<keyword>CYP2E1</keyword>
</DOC>